Navigation Links
White Blood Cell 'Waste Disposal' System Plays Critical Regulatory Role

A new research study identifies a critical inhibitory step that is a key component of the feedback circuit regulating the balance between neutrophil production and destruction. The research, published in the March issue of Immunity, suggests that the process for disposal of dying neutrophils is actively linked to neutrophil production. A clear understanding of the processes that control neutrophil turnover may contribute to the development of future therapeutics for conditions characterized by abnormal numbers of these critical immune cells.

Human neutrophils are white blood cells that are constantly being produced in the bone marrow and released into the blood stream where they migrate out of the blood and roam the body in search of potentially harmful foreign substances. Neutrophils have a short lifespan and often die via a programmed cell death pathway called apoptosis within a matter of hours. Dying neutrophils are recognized and ingested by cells in the body tissues called phagocytes.

Although the specific mechanisms that regulate the proper ratios of neutrophil production and destruction are not well understood, it is known that the immune signaling molecules IL-17 and G-CSF stimulate neutrophil production. In addition, a newly discovered molecule called IL-23 that is produced by phagocytes has been shown to stimulate IL-17 production. Dr. Klaus Ley and colleagues from the University of Virginia investigated whether ingestion of apoptotic neutrophils influenced IL-23 production by phagocytes.

The researchers observed that the amount of IL-23 produced by phagocytes was reduced when phagocytes actively ingested apoptotic neutrophils. Interestingly, mice with abnormal neutrophils that lacked the ability to migrate into body tissues where they would have encountered phagocytes exhibited elevated IL-23 and IL-17 levels. When these mice received an infusion of normal neutrophils that were capable of migration, the levels of IL-23 and IL-17 dro
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. White blood cell waste disposal system plays critical regulatory role
2. Great White shark evolution debate involves WSU Lake Campus geology professor
3. White blood cells of cancer-resistant mice overwhelm natural defenses of cancer cells
4. Whitefly spreads emerging plant viruses
5. White blood cells in lung produce histamine seen in allergies
6. Whiteflies and plant viruses can help each other to speed up biological invasion
7. Placenta Is A Rich Source Of Blood Stem Cells
8. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
9. Mystery Blood Vessel Disorder Implicated In Mini Strokes
10. Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells
11. Young Blood Revives Aging Muscles, Stanford Researchers Find

Post Your Comments:
(Date:11/22/2009)...xposed prenatally to tobacco smoke and during chil...HD, according to research done at Cincinnati Child...ates that up to 35 percent of ADHD cases in childr...y eliminating both of these environmental exposure...n , "Tobacco and lead exposure each have their ...
(Date:11/22/2009)...ber 18, 2009 -- A butterfly,s proboscis looks like... but it works more like a paper towel, according t...s to borrow the tricks of this piece of insect ana...d inside of cells. , Kornev will present his wor...ican Physical Society,s (APS) Division of Fluid Dy...
(Date:11/20/2009)...t work on many scientific and technological fronti...provided support that totals nearly $4.3 million f...ors under the American Recovery and Reinvestment A...ed grants for investigation of solar phenomena. Ph... will enhance the capabilities of NJIT,s Big Bear ...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Possible Gene Regions for Schizophrenia Located 50567 1Possible Gene Regions for Schizophrenia Located 50567 2Oral Cancer Foundation Praised for Its Social Media Efforts 50564 1Oral Cancer Foundation Praised for Its Social Media Efforts 50564 2Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 1Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 2Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 3
...t Design theorists have in America be broken by th... American evolutionist, makes the case for Darwin ...ign? Reporting from the front lines of America,s s...oology at UCL (University College London) on 16th ... Florida State University, will argue that Intelli...
...oculate everyone in the United States could be gro...tobacco plants, a University of Central Florida mo... a vaccine produced in UCF professor Henry Daniell...obacco plants survived lethal doses of anthrax adm...esearchers. The results of the NIH-funded study ar...
... a special green-algae gene into neurons of the ti...ave been able to elicit specific behavioral respon.... The work paves the way for better understanding ...th muscles, to regulate behavior in intact, living...on about the activity and function of specific neu...
Other Biology News:'Creationism is not science' ?making the case for Darwin at UCL 2Effective, safe anthrax vaccine can be grown in tobacco plants 2Effective, safe anthrax vaccine can be grown in tobacco plants 3Algal protein in worm neurons allows remote control of behavior by light 2
(Date:11/20/2009)... METTLER TOLEDO recently announc...Process Optimization Using At-Line Particle Charac..., 2009. In this webinar, the application of in si...p the design space and optimize a series of roller... rates, and roller compaction forces. , ...
(Date:11/19/2009)..., BLAUVELT, N.Y., Nov. 19 Dr. Ma...m extract, responds to a press release issued on N...garian company for making false and self-serving s...iences. ,, Dr. Hidvegi stated from his office ... that research on Avemar does not apply to AveULTR...
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNewswi...ave filed on November 16th, 2009 Flibanserin in th...yskinesia in Parkinson,s,disease for orphan drug s...cy,(EMEA). Levodopa-induced dyskinesia is a compli...nson,s and a serious burden to some of those,affec...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNewswi...ne program on one product candidate at an unexpect...date AD02 is planned to enter into,Phase II clinic...ny,immediately follows the completion of two Phase...ompany based its fast decision on the first interi...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
... Monday, March 10, 2008 at 8:30am, NEW YORK, Marc...icals, Inc. (Nasdaq: KERX ), announced top-line r...f Sulonex (sulodexide) for the,treatment of diabet...ase 3,clinical trial failed to meet the primary ob...oportion of patients that achieve therapeutic succ...
... Q3 2008 -, TORONTO, March 10 /PRNewswire-FirstCa... or the "Company"), a medical technology company,d...oday announced the,randomization of the 100th pati...e, double-blind placebo-controlled randomized clin...acy of Complex Neural Pulse,(CNP(TM)) therapy for ...
...,Anesiva, Inc. (Nasdaq: ANSV ) today announced th...ug Application (sNDA) with the U.S. Food and Drug,...Zingo to treat the pain,associated with peripheral...) (lidocaine hydrochloride monohydrate) powder int...he FDA to provide local analgesia,prior to periphe...
Other Biology Technology:Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 2Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 3Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 4Fralex reaches 100th patient milestone in fibromyalgia study 2Fralex reaches 100th patient milestone in fibromyalgia study 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 2Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 4
...ction Kit provides an extremely fast and efficient...lexes. Unlike other systems that require tedious o...ystem takes advantage of the highly selective Stre...tion under physiological conditions with low backg...
Histidine-tagged Protein Purification Resin from R&D Systems
GIBCO AmnioMAX-C100 Basal Medium liquid from Invitrogen
...ynabeads Tosylactivated (4.5 m). Hydrophobic nake...roups. For coupling of antibodies for cell applica...itial coupling with covalent binding of primary am...urringovernight. Coupling reactions can be perform...
Biology Products: